Autoimmune gastritis
| . | Macrocytic . | Normocytic . | Microcytic . |
|---|---|---|---|
| n | 29 | 48 | 83 |
| Mean age ± 1 SD, y | 62 ± 15 | 58 ± 17 | 41 ± 15 |
| Gender, M/F | 17/12 | 18/30 | 18/65 |
| Anemic, n (%) | 18 (62) | 19 (40) | 83 (100) |
| Cobalamin deficiency, n (%) | 29 (100) | 44 (92) | 38 (46) |
| Iron deficiency, n (%) | 3 (10) | 24 (50) | 83 (100) |
| Thyroid disease, n (%) | 3 (10) | 14 (29) | 15 (18) |
| Hypothyroid | 3 | 12 | 12 |
| Graves | 0 | 1 | 2 |
| Hashimoto | 0 | 1 | 1 |
| Intrinsic factor antibodies, % | 20 | 40 | 38 |
| Vitiligo | 2 | 0 | 0 |
| Diabetes mellitus, n (%) | 1 (3) | 4 (8) | 7 (8) |
| Neurologic complications, n (%) | 5 (17) | 2 (4) | 0 (0) |
| Gastric histology, n | 13 | 24 | 32 |
| Atrophic gastritis, n (%) | 9 (69) | 13 (54) | 13 (41) |
| Chronic gastritis, n (%) | 2 (15) | 9 (38) | 18 (56) |
| MALT, n (%) | 1 (8) | 1 (4) | 0 (0) |
| GI neoplasia, n (%) | 1 adeno Ca (8) | 1 polyp (4) | 1 polyp (3) |
| . | Macrocytic . | Normocytic . | Microcytic . |
|---|---|---|---|
| n | 29 | 48 | 83 |
| Mean age ± 1 SD, y | 62 ± 15 | 58 ± 17 | 41 ± 15 |
| Gender, M/F | 17/12 | 18/30 | 18/65 |
| Anemic, n (%) | 18 (62) | 19 (40) | 83 (100) |
| Cobalamin deficiency, n (%) | 29 (100) | 44 (92) | 38 (46) |
| Iron deficiency, n (%) | 3 (10) | 24 (50) | 83 (100) |
| Thyroid disease, n (%) | 3 (10) | 14 (29) | 15 (18) |
| Hypothyroid | 3 | 12 | 12 |
| Graves | 0 | 1 | 2 |
| Hashimoto | 0 | 1 | 1 |
| Intrinsic factor antibodies, % | 20 | 40 | 38 |
| Vitiligo | 2 | 0 | 0 |
| Diabetes mellitus, n (%) | 1 (3) | 4 (8) | 7 (8) |
| Neurologic complications, n (%) | 5 (17) | 2 (4) | 0 (0) |
| Gastric histology, n | 13 | 24 | 32 |
| Atrophic gastritis, n (%) | 9 (69) | 13 (54) | 13 (41) |
| Chronic gastritis, n (%) | 2 (15) | 9 (38) | 18 (56) |
| MALT, n (%) | 1 (8) | 1 (4) | 0 (0) |
| GI neoplasia, n (%) | 1 adeno Ca (8) | 1 polyp (4) | 1 polyp (3) |
Autoimmune gastritis: mode of presentation, associated findings, and results of endoscopy in 160 patients (Hershko et al46 ).
GI, gastrointestinal; MALT, mucosa-associated lymphoma.